- Initiated dosing at U.S. sites for VIRAGE, the Phase 2b clinical trial of VCN-01 in combination with chemotherapy for…
- Grace Breeding’s WDS, a proprietary and environmentally friendly formula to counteract crop climate stress, will be marketed under the…
First dual coronavirus-norovirus oral antiviral is scheduled for Phase 1 in healthy volunteers In vitro studies show broad-spectrum activity against…
ATLANTA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and…
Organization fully focused on product candidates and collaborations based on next-generation ADC platformsCapital resources expected to support current operating plan…
Recursion's Pipeline Recursion's internal pipeline as of Q2 2023Deployed new digital chemistry technology, together with NVIDIA, to predict the ligand-protein…
Männedorf, Switzerland, August 8, 2023 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to…
Conference Call Scheduled for Today at 8:30 a.m. Eastern TimeBERKELEY HEIGHTS, N.J., Aug. 08, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc.…
On track for Biologics License Application (BLA) submission in third quarter of 2023 Proceeds from $25 million registered direct offering…
MALVERN, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology…